Possibilities of dry eye syndrome therapy in various types of ametropia
https://doi.org/10.21516/2072-0076-2023-16-2-22-27
Abstract
Purpose: to evaluate the impact of Optinol treatment on the ocular surface state in medical students with various types of ametropia.
Material and methods. The study involved 3 groups of patients: two clinical groups and a control group. The first clinical group consisted of 34 students (68 eyes) with mild, moderate or high hyperopia, averagely aged 20.1 ± 0.5 years. The second clinical group consisted of 47 students (94 eyes) with mild, moderate or high myopia, average aged 20.6 ± 0.9 years. The control group was composed of 60 students (120 eyes), averagely aged 21.4 ± 1.2 years, with no ophthalmic pathologies. Each group received Optinol consecutively in three different formulations: Optinol® Gentle Repair: dexpanthenol 2 % and sodium hyaluronate 0.15 %, Optinol® Deep Hydration: sodium hyaluronate 0.4 %, Optinol® Express Moisturizer: sodium hyaluronate 0.21 %. The case histories of the patients and typical complaints were revealed by the questionnaire method. The state of the eyelids and the conjunctiva was assessed by biomicroscopy. To diagnose the dry eye syndrome (DES), special tests were used: LIPKOF, Schirmer and Norn tests.
Results. Despite the higher LIPKOF scores in the 1st (hyperopic) group, showing stage III as compared to the 2nd (myopic) group where it scored stage I, the Norn test score showed a stronger reduction in the 2nd group. The LIPKOF test improved in the hyperopic group, falling to 1.23 ± 0.10 mm (stage I), which corresponded to one conjunctival fold. The index of tear film stability (Norn's test) increased in group 1 by 3.1 ± 0.1 sec, and in group 2 by 2.2 ± 0.2 sec.
Conclusion. DES was found to be more frequent in hyperopic students. Optinol is a pathogenetically oriented drug, targeting tear production disorders and ocular surface changes. The drug demonstrates high efficacy, good tolerability and safety profile, so that it could be recommended for managing multiple types of ametropia.
About the Authors
M. A. Kovalevskaya
V.I. Burdenko Voronezh State Medical University
Russian Federation
Russian Federation
Maria A. Kovalevskaya, Dr. of Med. Sci., professor, head of chair of ophthalmology,
10, Studencheskaya St., Voronezh, 394036
V. B. Antonyan
V.I. Burdenko Voronezh State Medical University
Russian Federation
Russian Federation
Veronika B. Antonyan, ophthalmologist, assistant of chair of ophthalmology,
10, Studencheskaya St., Voronezh, 394036
M. I. Sergeeva
Olympus of Health Family clinic
Russian Federation
Russian Federation
Maria I. Sergeeva, Cand. of Med. Sci., ophthalmologist,
23/1, Teatralnaya St., Voronezh, 394006
References
1. Maychuk Yu.F., Yani E.V. The choice of drug therapy for various clinical forms of dry eye disease. Ophthalmology. 2014; 9(4): 58-64 (In Russ.). doi.org/10.18008/1816-5095-2012-4-58-64
2. Nelson JD, Nichols KK, Akpek EK, et al. TFOS DEWS II Introduction. Ocular Surface. 2017; 2015 (3): 269–75. doi:10.1016/j.jtos.2017.05.005
3. Tatarnikova E.B., Krivosheina O.I. Dry eye syndrome: modern aspects of etiology and pathogenesis. RMZH. Clinical ophthalmology. 2020; 20 (3): 128–32 (In Russ.). doi: 10.32364/2311-7729-2020-20-3-128-132
4. Kaur K, Gurnani, B, Nayak, S, et al. Digital eye strain-a comprehensive review. Ophthalmology and Therapy. 2022; 11 (5): 1655–80. doi:10.1007/s40123-022-00540-9
5. Mohan A, Sen P, Peeush P, Shah C, Jain E. Impact of online classes and home confinement on myopia progression in children during COVID-19 pandemic: digital eye strain among kids (DESK) study 4. Indian J Ophthalmol. 2022; 70 (1): 241–5. doi: 10.4103/ijo.IJO_1721_21
6. Munshi S, Varghese A, Dhar Munshi S. Computer vision syndrome – a common cause of unexplained visual symptoms in the modern era. Int J Clin Pract. 2017; 71 (7): e12962. doi: 10.1111/ijcp.12962
7. Ostanina D.A., Korobintseva K.N. The prevalence of dry eye syndrome among young people. Vestnik soveta molodykh uchenykh i spetsialistov Cheljabinskoj oblasti. 2018; 1 (1): 38–41 (In Russ.).
8. Jiang X, Tarczy-Hornoch K, Stram D, et al. Population-based pediatric eye disease study consortium. Prevalence, characteristics, and risk factors of moderate or high hyperopia among multiethnic children 6 to 72 months of age: A pooled analysis of individual participant data. Ophthalmology. 2019; 126 (7): 989 99. doi: 10.1016/j.ophtha.2019.02.021
9. Fahmy RM, Aldarwesh A. Correlation between dry eye and refractive error in Saudi young adults using noninvasive Keratograph 4. Indian J Ophthalmol. 2018; 66 (5): 653–6. doi: 10.4103/ijo.IJO_1103_17
10. Prozornaya L.P., Brzhesky V.V. Particular features of the dry eye syndrome clinical course against the background of blepharoconjunctivitis. Oftal’mologicheski vedomosti. 2008; 1 (3): 7–14 (In Russ.).
11. Polunin G.S., Polunina E.G. From dry eye to team film disease. Ophthalmology in Russia. 2012; 9 (2): 4–7 (In Russ.). https://doi.org/10.18008/1816-5095-2012-2-4-7
12. Lemp A. Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes. CLAO J. 1995; 21 (4): 221–32.
13. Markov I.A., Majchuk Yu.F., Majchuk D.Yu., et al. Gel-like artificial tears with antiseptic and reparative action. Patent RU № 2679319; 2019 (In Russ.).
14. Kovalevskaya M.A., Milyutkina S.O., Bogatyreva E.S., et al. Screening methods of examination in the implementation of the program for the early detection of diseases of the eye (glaucoma, age-related macular degeneration, dry eye syndrome). Novosti glaucomy. 2016; 37 (1): 109–12 (In Russ.).
15. Al-Mohtaseb Z, Schachter S, Shen Lee B, Garlich J, Trattler W. The relationship between dry eye disease and digital screen use. Clinical Ophthalmology. 2021; 15: 3811–20. doi:10.2147/OPTH.S321591
Review
For citations:
Kovalevskaya M.A., Antonyan V.B., Sergeeva M.I. Possibilities of dry eye syndrome therapy in various types of ametropia. Russian Ophthalmological Journal. 2023;16(2):22-27. (In Russ.) https://doi.org/10.21516/2072-0076-2023-16-2-22-27
Views:
438
Email this article 